As of the most recent data, NSTG shows a ROE of 329.14%. That is above the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 20.86%. Nanostring Technologies is at 329.14%, which is higher that average. That is roughly 1478.1% above the sector mean. Use the comparison chart on this page to see how NSTG stacks up against individual peers as well.

Check the historical chart to see whether NSTG's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Nanostring Technologies with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Nanostring Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 329.14%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 20.86%, while NSTG is at 329.14%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.